Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

97 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Novel Insights into the Management of Patients with Very High Cardiovascular Risk Eligible for PCSK9 Inhibitor Treatment: Baseline Findings from the PERI-DYS Study.
Laufs U, Birkenfeld AL, Fraass U, Hohenstein B, Siegert C, Klotsche J, Steinhagen-Thiessen E, Pittrow D, Dexl S, Salmen S, Schettler VJJ, Parhofer KG; Collaborators in the PERI-DYS Study. Laufs U, et al. Among authors: hohenstein b. Cardiovasc Drugs Ther. 2024 Feb;38(1):119-129. doi: 10.1007/s10557-022-07386-0. Epub 2022 Sep 30. Cardiovasc Drugs Ther. 2024. PMID: 36178485 Free PMC article.
The German Lipoprotein Apheresis Registry-Summary of the eleventh annual report.
Schettler VJJ, Selke N, Jenke S, Zimmermann T, Schlieper G, Bernhardt W, Heigl F, Grützmacher P, Löhlein I, Klingel R, Hohenstein B, Ramlow W, Vogt A, Julius U; Scientific Board of GLAR for the German Apheresis Working Group. Schettler VJJ, et al. Among authors: hohenstein b. Atherosclerosis. 2024 Nov;398:118601. doi: 10.1016/j.atherosclerosis.2024.118601. Epub 2024 Sep 19. Atherosclerosis. 2024. PMID: 39342791
SARS-CoV-2 infection in chronic kidney disease patients with pre-existing dialysis: description across different pandemic intervals and effect on disease course (mortality).
Pilgram L, Eberwein L, Jensen BO, Jakob CEM, Koehler FC, Hower M, Kielstein JT, Stecher M, Hohenstein B, Prasser F, Westhoff T, de Miranda SMN, Vehreschild MJGT, Lanznaster J, Dolff S; LEOSS study group. Pilgram L, et al. Among authors: hohenstein b. Infection. 2023 Feb;51(1):71-81. doi: 10.1007/s15010-022-01826-7. Epub 2022 Apr 29. Infection. 2023. PMID: 35486356 Free PMC article.
SGLT2-Inhibition in Patients With Alport Syndrome.
Boeckhaus J, Gale DP, Simon J, Ding J, Zhang Y, Bergmann C, Turner AN, Hall M, Sayer JA, Srivastava S, Kang HG, Cerkauskaite-Kerpauskiene A, Gillion V, Claes KJ, Krueger B, de Fallois J, Walden U, Choi M, Schueler M, Mueller RU, Todorova P, Hohenstein B, Zeisberg M, Friede T, Knebelmann B, Halbritter J, Gross O. Boeckhaus J, et al. Among authors: hohenstein b. Kidney Int Rep. 2024 Sep 24;9(12):3490-3500. doi: 10.1016/j.ekir.2024.09.014. eCollection 2024 Dec. Kidney Int Rep. 2024. PMID: 39698346 Free PMC article.
97 results